Benzimidazole derivatives, their preparation and use
Abstract
Abstract A compound having the formula ##STR1## wherein R 1 is hydrogen, NH 2 or C 1-6 -alkyl which may be branched; X is O, S, NCN; Y is O, S; R 4 , R 5 , R 6 and R 7 independently of each other are hydrogen, halogen, CF 3 , NO 2 , NH 2 , OH, C 1-6 -alkoxy, C(═O)-phenyl or SO 2 NR I R II wherein R I and R II independently are hydrogen or C 1-6 -alkyl; R 11 is hydrogen, halogen, NO 2 or SO 2 NR'R" wherein R' and R" independently are hydrogen or C 1-6 -alkyl; R 13 is hydrogen, halogen, phenyl, CF 3 , NO 2 ; R 12 is hydrogen or together with R 13 forms a C 4-7 -carbocyclic ring which may be aromatic or partially saturated; R 14 is hydrogen or together with R 13 forms a C 4-7 -carbocyclic ring which may be aromatic or partially saturated; pharmaceutical compositions thereof, and a method of treating a disease in a mammal, including a human, responsive to opening of potassium channels, which comprises administering to a mammal in need thereof an effective amount of a compound as first above indicated, are disclosed.
Inventors
- 👤 Soren-Peter Olesen
- 👤 Frank Watjen
Bibliographic Details
Claims Analysis
Total Claims: 9References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-04-05 | 1996-10-05 | 1997-04-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-04-05 | 2000-10-05 | 2001-04-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-04-05 | 2004-10-05 | 2005-04-06 | $7700.00 | Window Closed / Lapsed |